WASHINGTON -- The Neuroguard carotid stent system, with its integrated embolic filter, continued to show good results at 2 ...

The Parkview Heart Institute has been selected by medical technology firm Medtronic as one of 65 hospitals globally to ...

NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has received FDA approval to move forward with its Virtue Trial ...

The drug-eluting stent market is anticipated to grow at a CAGR of 8.20% from US$11.499 billion in 2025 to US$17.049 billion ...